MTOR and nonpapillary renal cell carcinoma: PI3K/AKT/mTOR/SREBP2 pathway is upregulated by VHL mutations and the subsequent stabilization of HIFα, contributing to the accumulation of intracellular cholesteryl esters and facilitating ccRCC development (Zhang et al., 2024).